Valuation (74%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 7.23 | 5.03 |
| PEG Ratio (TTM) | 0.07 | -1.16 |
| P/S Ratio (TTM) | 7.21 | 49.10 |
| P/B Ratio (TTM) | 1.03 | 0.93 |
| P/FCF Ratio (TTM) | 6.32 | 19.54 |
| Price to 5YR AVG Earnings Ratio | 56.98 | 27.15 |
| Price to 5YR AVG FCF Ratio | 11.83 | 28.09 |
Profitability (63%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 13.95% | 1.18% |
| ROE (TTM) | 14.63% | 5.34% |
| Net Profit Margin (TTM) | 99.52% | 28.82% |
| ROIC 5YR AVG | 1.73% | 7.86% |
Growth (100%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 1,369.35% | 222.61% | 170.85% |
| Revenue | 105.07% | 243.24% | 183.40% |
| Net Income | 1,416.87% | 220.91% | 169.84% |
| Cash Flow | 14.89% | 148.52% | 254.82% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | 1.62 |
| Quick Ratio (TTM) | N/A | 1.59 |
| D/E Ratio (TTM) | N/A | 0.72 |
| Interest Coverage (TTM) | N/A | 21.08 |
| Piotroski F-Score | 7 | 6 |
| Altman Z-Score | 35.84 | 7.36 |
| LTL to 5YR AVG FCF | N/A | 9.24 |
| Shares Outstanding Growth 5YR AVG | -0.14% | -0.74% |